Outcomes for efavirenz versus nevirapine-containing regimens for treatment of HIV-1 infection: a systematic review and meta-analysis
about
Efavirenz-Based Regimens in Antiretroviral-Naive HIV-Infected Patients: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsPregnancy rates in HIV-positive women using contraceptives and efavirenz-based or nevirapine-based antiretroviral therapy in Kenya: a retrospective cohort studyEffectiveness of a Treatment Switch to Nevirapine plus Tenofovir and Emtricitabine (or Lamivudine) in Adults with HIV-1 Suppressed ViremiaModeling Outcomes of First-Line Antiretroviral Therapy and Rate of CD4 Counts Change among a Cohort of HIV/AIDS Patients in Ethiopia: A Retrospective Cohort StudyEfavirenz or nevirapine in three-drug combination therapy with two nucleoside or nucleotide-reverse transcriptase inhibitors for initial treatment of HIV infection in antiretroviral-naïve individualsLong-term virological outcome in children on antiretroviral therapy in the UK and Ireland.Guidelines for antiretroviral therapy in HIV-1 infected adults and adolescents 2014, Thailand.Quality of life in patients treated with first-line antiretroviral therapy containing nevirapine or efavirenz in Uganda: a prospective non-randomized study.Challenges Associated with Management of Buruli Ulcer/Human Immunodeficiency Virus Coinfection in a Treatment Center in Ghana: A Case Series Study.Brief Report: Hormonal Contraception Is Not Associated With Reduced ART Effectiveness Among Women Initiating ART: Evidence From Longitudinal Data.Low-Frequency Drug Resistance in HIV-Infected Ugandans on Antiretroviral Treatment Is Associated with Regimen Failure.A Randomized Switch From Nevirapine-Based Antiretroviral Therapy to Single Tablet Rilpivirine/Emtricitabine/Tenofovir Disoproxil Fumarate in Virologically Suppressed Human Immunodeficiency Virus-1-Infected Rwandans.Effectiveness and safety of concurrent use of first-line antiretroviral and antituberculous drugs in rwanda.Cervicovaginal HIV-1 shedding in women taking antiretroviral therapy in Burkina Faso: a longitudinal study.Concomitant contraceptive implant and efavirenz use in women living with HIV: perspectives on current evidence and policy implications for family planning and HIV treatment guidelines.Virologic Response to First-line Efavirenz- or Nevirapine-based Antiretroviral Therapy in HIV-infected African Children.Accumulation of HIV-1 drug resistance after continued virological failure on first-line ART in adults and children in sub-Saharan Africa.Choice of initial antiretroviral drugs and treatment outcomes among HIV-infected patients in sub-Saharan Africa: systematic review and meta-analysis of observational studies.Patterns and Predictors of First-Line Antiretroviral Therapy Modification in HIV-1-Infected Adults in a Large Urban Outpatient Cohort in Nigeria.Lipid-based nutrient supplements do not affect efavirenz but lower plasma nevirapine concentrations in Ethiopian adult HIV patients.Paediatric European Network for Treatment of AIDS (PENTA) guidelines for treatment of paediatric HIV-1 infection 2015: optimizing health in preparation for adult life.Editorial Commentary: Scaling Up Antiretroviral Therapy in Africa: Are We There Yet?Ten year experience with antiretroviral treatment in Cambodia: Trends in patient characteristics and treatment outcomes.Sensitive detection of HIV-1 resistance to Zidovudine and impact on treatment outcomes in low- to middle-income countries.Long-term viral suppression and immune recovery during first-line antiretroviral therapy: a study of an HIV-infected adult cohort in Hanoi, Vietnam.A Genome-Wide Association Study Identifies a Candidate Gene Associated With Atazanavir Exposure Measured in Hair.A comparative study of logistic regression based machine learning techniques for prediction of early virological suppression in antiretroviral initiating HIV patients
P2860
Q28081266-4A572A59-5CE7-4187-8CAF-F15BA1977B12Q28081707-F648E316-A86D-4416-9408-4DBCA5782CF4Q28548630-D4976C1F-1E9F-4AC4-8001-19039D2DBDB7Q28555157-B2386719-266C-4EAE-B510-ACDCC089B730Q30240127-4F6B6C6F-5ED9-4680-916D-D4652F2B2760Q34410947-97E8DC43-8836-4186-9A96-B3155DB4B599Q35530299-DA7C9ED8-A2A8-4175-BEEE-9227EE8DC8D8Q35717749-2E3421D4-A59C-4C33-890F-B400AF3B6C6AQ35933855-3242F2FF-BDA3-47A5-8FC7-F8CAA1BFBCF7Q36343568-929F6DC0-2009-4B65-B513-6DF62DACD192Q36933330-F1634C88-38D9-401F-9E7E-AC2ABDD88FF7Q37305526-B934019C-1F7C-4A27-8789-30293CC4C2DDQ37593420-51BA4B53-0BC7-4637-A258-2E7F4D32DBE8Q37692477-170D463B-C60B-40D1-A454-3D854302240CQ38771869-69936FF1-8F60-497B-8CD2-95D695445442Q38850249-D5852F59-9283-4DF9-93FE-FA993331D44AQ38854117-C63004E7-17E9-4C3E-B812-68C1415EE3CDQ40070125-A6651DAB-1B61-44E1-BD8E-BF4CFA348216Q40247957-54F069A5-2442-47B7-9A72-15DBECB40C90Q40280595-71D702A7-1084-499E-A4D7-76A61616E9C0Q41505058-BC54625E-24A1-4BC7-9189-0ECB8DB43DE8Q44739822-1FDFB7AC-E9EB-40E6-BD13-24F4B55929B2Q46251979-EEDD4DA2-4810-40F5-AB03-72DF9D1ED7AAQ46499496-745C3CC1-771C-4504-8B5F-0933278AD3BBQ47568887-4089AD4E-EA97-40AC-ADF9-265D34DFF971Q50120171-D89FBD2B-01F2-4BB8-A839-648B86055389Q56909671-02076F08-D94D-451F-993F-50DDD0B4DC34
P2860
Outcomes for efavirenz versus nevirapine-containing regimens for treatment of HIV-1 infection: a systematic review and meta-analysis
description
2013 nî lūn-bûn
@nan
2013 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Outcomes for efavirenz versus ...... matic review and meta-analysis
@ast
Outcomes for efavirenz versus ...... matic review and meta-analysis
@en
Outcomes for efavirenz versus ...... matic review and meta-analysis
@nl
type
label
Outcomes for efavirenz versus ...... matic review and meta-analysis
@ast
Outcomes for efavirenz versus ...... matic review and meta-analysis
@en
Outcomes for efavirenz versus ...... matic review and meta-analysis
@nl
prefLabel
Outcomes for efavirenz versus ...... matic review and meta-analysis
@ast
Outcomes for efavirenz versus ...... matic review and meta-analysis
@en
Outcomes for efavirenz versus ...... matic review and meta-analysis
@nl
P2093
P2860
P31
P921
P3181
P1433
P1476
Outcomes for efavirenz versus ...... matic review and meta-analysis
@en
P2093
Nathan Ford
Prinitha Pillay
Rashida A. Ferrand
Zara Shubber
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0068995
P407
P5008
P577
2013-01-01T00:00:00Z
2013-07-22T00:00:00Z